Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases
Hepatobiliary diseases and their complications cause the accumulation of toxic bile acids (BA) in the liver, blood, and other tissues, which may exacerbate the underlying condition and lead to unfavorable prognosis. To develop and validate prognostic biomarkers for the prediction of complications of...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2022/5473752 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565400203689984 |
|---|---|
| author | Wenkuan Li Jawaher Abdullah Alamoudi Nagsen Gautam Devendra Kumar Macro Olivera Yeongjin Gwon Sandeep Mukgerjee Yazen Alnouti |
| author_facet | Wenkuan Li Jawaher Abdullah Alamoudi Nagsen Gautam Devendra Kumar Macro Olivera Yeongjin Gwon Sandeep Mukgerjee Yazen Alnouti |
| author_sort | Wenkuan Li |
| collection | DOAJ |
| description | Hepatobiliary diseases and their complications cause the accumulation of toxic bile acids (BA) in the liver, blood, and other tissues, which may exacerbate the underlying condition and lead to unfavorable prognosis. To develop and validate prognostic biomarkers for the prediction of complications of cholestatic liver disease based on urinary BA indices, liquid chromatography-tandem mass spectrometry was used to analyze urine samples from 257 patients with cholestatic liver diseases during a 7-year follow-up period. The urinary BA profile and non-BA parameters were monitored, and logistic regression models were used to predict the prognosis of hepatobiliary disease-related complications. Urinary BA indices were applied to quantify the composition, metabolism, hydrophilicity, and toxicity of the BA profile. We have developed and validated the bile-acid liver disease complication (BALDC) model based on BA indices using logistic regression model, to predict the prognosis of cholestatic liver disease complications including ascites. The mixed BA and non-BA model was the most accurate and provided higher area under the receiver operating characteristic (ROC) and smaller akaike information criterion (AIC) values compared to both non-BA and MELD (models for end stage liver disease) models. Therefore, the mixed BA and non-BA model could be used to predict the development of ascites in patients diagnosed with liver disease at early stages of intervention. This will help physicians to make a better decision when treating hepatobiliary disease-related ascites. |
| format | Article |
| id | doaj-art-a2a7adde4045496f83621ff559eb44cb |
| institution | Kabale University |
| issn | 2090-3456 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Hepatology |
| spelling | doaj-art-a2a7adde4045496f83621ff559eb44cb2025-02-03T01:07:55ZengWileyInternational Journal of Hepatology2090-34562022-01-01202210.1155/2022/5473752Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver DiseasesWenkuan Li0Jawaher Abdullah Alamoudi1Nagsen Gautam2Devendra Kumar3Macro Olivera4Yeongjin Gwon5Sandeep Mukgerjee6Yazen Alnouti7Department of Pharmaceutical SciencesDepartment of Pharmaceutical SciencesDepartment of Pharmaceutical SciencesDepartment of Pharmaceutical SciencesDepartment of Internal MedicineDepartment of BiostatisticsDepartment of Internal MedicineDepartment of Pharmaceutical SciencesHepatobiliary diseases and their complications cause the accumulation of toxic bile acids (BA) in the liver, blood, and other tissues, which may exacerbate the underlying condition and lead to unfavorable prognosis. To develop and validate prognostic biomarkers for the prediction of complications of cholestatic liver disease based on urinary BA indices, liquid chromatography-tandem mass spectrometry was used to analyze urine samples from 257 patients with cholestatic liver diseases during a 7-year follow-up period. The urinary BA profile and non-BA parameters were monitored, and logistic regression models were used to predict the prognosis of hepatobiliary disease-related complications. Urinary BA indices were applied to quantify the composition, metabolism, hydrophilicity, and toxicity of the BA profile. We have developed and validated the bile-acid liver disease complication (BALDC) model based on BA indices using logistic regression model, to predict the prognosis of cholestatic liver disease complications including ascites. The mixed BA and non-BA model was the most accurate and provided higher area under the receiver operating characteristic (ROC) and smaller akaike information criterion (AIC) values compared to both non-BA and MELD (models for end stage liver disease) models. Therefore, the mixed BA and non-BA model could be used to predict the development of ascites in patients diagnosed with liver disease at early stages of intervention. This will help physicians to make a better decision when treating hepatobiliary disease-related ascites.http://dx.doi.org/10.1155/2022/5473752 |
| spellingShingle | Wenkuan Li Jawaher Abdullah Alamoudi Nagsen Gautam Devendra Kumar Macro Olivera Yeongjin Gwon Sandeep Mukgerjee Yazen Alnouti Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases International Journal of Hepatology |
| title | Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases |
| title_full | Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases |
| title_fullStr | Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases |
| title_full_unstemmed | Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases |
| title_short | Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases |
| title_sort | urinary ba indices as prognostic biomarkers for complications associated with liver diseases |
| url | http://dx.doi.org/10.1155/2022/5473752 |
| work_keys_str_mv | AT wenkuanli urinarybaindicesasprognosticbiomarkersforcomplicationsassociatedwithliverdiseases AT jawaherabdullahalamoudi urinarybaindicesasprognosticbiomarkersforcomplicationsassociatedwithliverdiseases AT nagsengautam urinarybaindicesasprognosticbiomarkersforcomplicationsassociatedwithliverdiseases AT devendrakumar urinarybaindicesasprognosticbiomarkersforcomplicationsassociatedwithliverdiseases AT macroolivera urinarybaindicesasprognosticbiomarkersforcomplicationsassociatedwithliverdiseases AT yeongjingwon urinarybaindicesasprognosticbiomarkersforcomplicationsassociatedwithliverdiseases AT sandeepmukgerjee urinarybaindicesasprognosticbiomarkersforcomplicationsassociatedwithliverdiseases AT yazenalnouti urinarybaindicesasprognosticbiomarkersforcomplicationsassociatedwithliverdiseases |